List of Tables
Table 1. Global Antibodies for Research Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Antibodies for Research Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Antibodies for Research Market Competitive Situation by Manufacturers in 2022
Table 4. Global Antibodies for Research Sales (mg) of Key Manufacturers (2018-2023)
Table 5. Global Antibodies for Research Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Antibodies for Research Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Antibodies for Research Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Antibodies for Research Average Price (US$/mg) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Antibodies for Research, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Antibodies for Research, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Antibodies for Research, Product Type & Application
Table 12. Global Key Manufacturers of Antibodies for Research, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Antibodies for Research by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antibodies for Research as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Antibodies for Research Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Antibodies for Research Sales by Region (2018-2023) & (mg)
Table 18. Global Antibodies for Research Sales Market Share by Region (2018-2023)
Table 19. Global Antibodies for Research Sales by Region (2024-2029) & (mg)
Table 20. Global Antibodies for Research Sales Market Share by Region (2024-2029)
Table 21. Global Antibodies for Research Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Antibodies for Research Revenue Market Share by Region (2018-2023)
Table 23. Global Antibodies for Research Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Antibodies for Research Revenue Market Share by Region (2024-2029)
Table 25. North America Antibodies for Research Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Antibodies for Research Sales by Country (2018-2023) & (mg)
Table 27. North America Antibodies for Research Sales by Country (2024-2029) & (mg)
Table 28. North America Antibodies for Research Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Antibodies for Research Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Antibodies for Research Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Antibodies for Research Sales by Country (2018-2023) & (mg)
Table 32. Europe Antibodies for Research Sales by Country (2024-2029) & (mg)
Table 33. Europe Antibodies for Research Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Antibodies for Research Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Antibodies for Research Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Antibodies for Research Sales by Region (2018-2023) & (mg)
Table 37. Asia Pacific Antibodies for Research Sales by Region (2024-2029) & (mg)
Table 38. Asia Pacific Antibodies for Research Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Antibodies for Research Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Antibodies for Research Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Antibodies for Research Sales by Country (2018-2023) & (mg)
Table 42. Latin America Antibodies for Research Sales by Country (2024-2029) & (mg)
Table 43. Latin America Antibodies for Research Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Antibodies for Research Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Antibodies for Research Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Antibodies for Research Sales by Country (2018-2023) & (mg)
Table 47. Middle East & Africa Antibodies for Research Sales by Country (2024-2029) & (mg)
Table 48. Middle East & Africa Antibodies for Research Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Antibodies for Research Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Antibodies for Research Sales (mg) by Type (2018-2023)
Table 51. Global Antibodies for Research Sales (mg) by Type (2024-2029)
Table 52. Global Antibodies for Research Sales Market Share by Type (2018-2023)
Table 53. Global Antibodies for Research Sales Market Share by Type (2024-2029)
Table 54. Global Antibodies for Research Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Antibodies for Research Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Antibodies for Research Revenue Market Share by Type (2018-2023)
Table 57. Global Antibodies for Research Revenue Market Share by Type (2024-2029)
Table 58. Global Antibodies for Research Price (US$/mg) by Type (2018-2023)
Table 59. Global Antibodies for Research Price (US$/mg) by Type (2024-2029)
Table 60. Global Antibodies for Research Sales (mg) by Application (2018-2023)
Table 61. Global Antibodies for Research Sales (mg) by Application (2024-2029)
Table 62. Global Antibodies for Research Sales Market Share by Application (2018-2023)
Table 63. Global Antibodies for Research Sales Market Share by Application (2024-2029)
Table 64. Global Antibodies for Research Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Antibodies for Research Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Antibodies for Research Revenue Market Share by Application (2018-2023)
Table 67. Global Antibodies for Research Revenue Market Share by Application (2024-2029)
Table 68. Global Antibodies for Research Price (US$/mg) by Application (2018-2023)
Table 69. Global Antibodies for Research Price (US$/mg) by Application (2024-2029)
Table 70. Merck Corporation Information
Table 71. Merck Description and Business Overview
Table 72. Merck Antibodies for Research Sales (mg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2018-2023)
Table 73. Merck Antibodies for Research Product
Table 74. Merck Recent Developments/Updates
Table 75. Johnson and Johnson Services Corporation Information
Table 76. Johnson and Johnson Services Description and Business Overview
Table 77. Johnson and Johnson Services Antibodies for Research Sales (mg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2018-2023)
Table 78. Johnson and Johnson Services Antibodies for Research Product
Table 79. Johnson and Johnson Services Recent Developments/Updates
Table 80. Eli Lilly and Company Corporation Information
Table 81. Eli Lilly and Company Description and Business Overview
Table 82. Eli Lilly and Company Antibodies for Research Sales (mg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2018-2023)
Table 83. Eli Lilly and Company Antibodies for Research Product
Table 84. Eli Lilly and Company Recent Developments/Updates
Table 85. Bio-Rad Laboratories, Inc Corporation Information
Table 86. Bio-Rad Laboratories, Inc Description and Business Overview
Table 87. Bio-Rad Laboratories, Inc Antibodies for Research Sales (mg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2018-2023)
Table 88. Bio-Rad Laboratories, Inc Antibodies for Research Product
Table 89. Bio-Rad Laboratories, Inc Recent Developments/Updates
Table 90. Cell Signalling Technology Corporation Information
Table 91. Cell Signalling Technology Description and Business Overview
Table 92. Cell Signalling Technology Antibodies for Research Sales (mg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2018-2023)
Table 93. Cell Signalling Technology Antibodies for Research Product
Table 94. Cell Signalling Technology Recent Developments/Updates
Table 95. PerkinEImer Corporation Information
Table 96. PerkinEImer Description and Business Overview
Table 97. PerkinEImer Antibodies for Research Sales (mg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2018-2023)
Table 98. PerkinEImer Antibodies for Research Product
Table 99. PerkinEImer Recent Developments/Updates
Table 100. Rockland Immunochemicals Corporation Information
Table 101. Rockland Immunochemicals Description and Business Overview
Table 102. Rockland Immunochemicals Antibodies for Research Sales (mg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2018-2023)
Table 103. Rockland Immunochemicals Antibodies for Research Product
Table 104. Rockland Immunochemicals Recent Developments/Updates
Table 105. Novartis Corporation Information
Table 106. Novartis Description and Business Overview
Table 107. Novartis Antibodies for Research Sales (mg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2018-2023)
Table 108. Novartis Antibodies for Research Product
Table 109. Novartis Recent Developments/Updates
Table 110. BD Corporation Information
Table 111. BD Description and Business Overview
Table 112. BD Antibodies for Research Sales (mg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2018-2023)
Table 113. BD Antibodies for Research Product
Table 114. BD Recent Developments/Updates
Table 115. Abcam Corporation Information
Table 116. Abcam Description and Business Overview
Table 117. Abcam Antibodies for Research Sales (mg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2018-2023)
Table 118. Abcam Antibodies for Research Product
Table 119. Abcam Recent Developments/Updates
Table 120. Kamiya Biomedical Corporation Information
Table 121. Kamiya Biomedical Description and Business Overview
Table 122. Kamiya Biomedical Antibodies for Research Sales (mg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2018-2023)
Table 123. Kamiya Biomedical Antibodies for Research Product
Table 124. Kamiya Biomedical Recent Developments/Updates
Table 125. AMSBIO Corporation Information
Table 126. AMSBIO Description and Business Overview
Table 127. AMSBIO Antibodies for Research Sales (mg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2018-2023)
Table 128. AMSBIO Antibodies for Research Product
Table 129. AMSBIO Recent Developments/Updates
Table 130. Thermo Fisher Scientific Corporation Information
Table 131. Thermo Fisher Scientific Description and Business Overview
Table 132. Thermo Fisher Scientific Antibodies for Research Sales (mg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2018-2023)
Table 133. Thermo Fisher Scientific Antibodies for Research Product
Table 134. Thermo Fisher Scientific Recent Developments/Updates
Table 135. GeneTex Corporation Information
Table 136. GeneTex Description and Business Overview
Table 137. GeneTex Antibodies for Research Sales (mg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2018-2023)
Table 138. GeneTex Antibodies for Research Product
Table 139. GeneTex Recent Developments/Updates
Table 140. MCE Corporation Information
Table 141. MCE Description and Business Overview
Table 142. MCE Antibodies for Research Sales (mg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2018-2023)
Table 143. MCE Antibodies for Research Product
Table 144. MCE Recent Developments/Updates
Table 145. Shanghai Yanmai Biotechnology Corporation Information
Table 146. Shanghai Yanmai Biotechnology Description and Business Overview
Table 147. Shanghai Yanmai Biotechnology Antibodies for Research Sales (mg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2018-2023)
Table 148. Shanghai Yanmai Biotechnology Antibodies for Research Product
Table 149. Shanghai Yanmai Biotechnology Recent Developments/Updates
Table 150. Shanghai LONG ISLAND Antibody Diagnostica Corporation Information
Table 151. Shanghai LONG ISLAND Antibody Diagnostica Description and Business Overview
Table 152. Shanghai LONG ISLAND Antibody Diagnostica Antibodies for Research Sales (mg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2018-2023)
Table 153. Shanghai LONG ISLAND Antibody Diagnostica Antibodies for Research Product
Table 154. Shanghai LONG ISLAND Antibody Diagnostica Recent Developments/Updates
Table 155. SUNSHINE GUOJIAN PHARMACEUTICAL Corporation Information
Table 156. SUNSHINE GUOJIAN PHARMACEUTICAL Description and Business Overview
Table 157. SUNSHINE GUOJIAN PHARMACEUTICAL Antibodies for Research Sales (mg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2018-2023)
Table 158. SUNSHINE GUOJIAN PHARMACEUTICAL Antibodies for Research Product
Table 159. SUNSHINE GUOJIAN PHARMACEUTICAL Recent Developments/Updates
Table 160. Shanghai Junshi Biosciences Corporation Information
Table 161. Shanghai Junshi Biosciences Description and Business Overview
Table 162. Shanghai Junshi Biosciences Antibodies for Research Sales (mg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2018-2023)
Table 163. Shanghai Junshi Biosciences Antibodies for Research Product
Table 164. Shanghai Junshi Biosciences Recent Developments/Updates
Table 165. Key Raw Materials Lists
Table 166. Raw Materials Key Suppliers Lists
Table 167. Antibodies for Research Distributors List
Table 168. Antibodies for Research Customers List
Table 169. Antibodies for Research Market Trends
Table 170. Antibodies for Research Market Drivers
Table 171. Antibodies for Research Market Challenges
Table 172. Antibodies for Research Market Restraints
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Antibodies for Research
Figure 2. Global Antibodies for Research Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Antibodies for Research Market Share by Type in 2022 & 2029
Figure 4. Monoclonal Product Picture
Figure 5. Polyclonal Product Picture
Figure 6. Global Antibodies for Research Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global Antibodies for Research Market Share by Application in 2022 & 2029
Figure 8. Oncology
Figure 9. Neurobiology
Figure 10. Immunology
Figure 11. Others
Figure 12. Global Antibodies for Research Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Antibodies for Research Market Size (2018-2029) & (US$ Million)
Figure 14. Global Antibodies for Research Sales (2018-2029) & (mg)
Figure 15. Global Antibodies for Research Average Price (US$/mg) & (2018-2029)
Figure 16. Antibodies for Research Report Years Considered
Figure 17. Antibodies for Research Sales Share by Manufacturers in 2022
Figure 18. Global Antibodies for Research Revenue Share by Manufacturers in 2022
Figure 19. The Global 5 and 10 Largest Antibodies for Research Players: Market Share by Revenue in 2022
Figure 20. Antibodies for Research Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 21. Global Antibodies for Research Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 22. North America Antibodies for Research Sales Market Share by Country (2018-2029)
Figure 23. North America Antibodies for Research Revenue Market Share by Country (2018-2029)
Figure 24. United States Antibodies for Research Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Canada Antibodies for Research Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 26. Europe Antibodies for Research Sales Market Share by Country (2018-2029)
Figure 27. Europe Antibodies for Research Revenue Market Share by Country (2018-2029)
Figure 28. Germany Antibodies for Research Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. France Antibodies for Research Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. U.K. Antibodies for Research Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Italy Antibodies for Research Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Russia Antibodies for Research Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Asia Pacific Antibodies for Research Sales Market Share by Region (2018-2029)
Figure 34. Asia Pacific Antibodies for Research Revenue Market Share by Region (2018-2029)
Figure 35. China Antibodies for Research Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. Japan Antibodies for Research Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. South Korea Antibodies for Research Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. India Antibodies for Research Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Australia Antibodies for Research Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. China Taiwan Antibodies for Research Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Southeast Asia Antibodies for Research Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Latin America Antibodies for Research Sales Market Share by Country (2018-2029)
Figure 43. Latin America Antibodies for Research Revenue Market Share by Country (2018-2029)
Figure 44. Mexico Antibodies for Research Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Brazil Antibodies for Research Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Argentina Antibodies for Research Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Colombia Antibodies for Research Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Middle East & Africa Antibodies for Research Sales Market Share by Country (2018-2029)
Figure 49. Middle East & Africa Antibodies for Research Revenue Market Share by Country (2018-2029)
Figure 50. Turkey Antibodies for Research Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Saudi Arabia Antibodies for Research Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. UAE Antibodies for Research Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Global Sales Market Share of Antibodies for Research by Type (2018-2029)
Figure 54. Global Revenue Market Share of Antibodies for Research by Type (2018-2029)
Figure 55. Global Antibodies for Research Price (US$/mg) by Type (2018-2029)
Figure 56. Global Sales Market Share of Antibodies for Research by Application (2018-2029)
Figure 57. Global Revenue Market Share of Antibodies for Research by Application (2018-2029)
Figure 58. Global Antibodies for Research Price (US$/mg) by Application (2018-2029)
Figure 59. Antibodies for Research Value Chain
Figure 60. Antibodies for Research Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
